Cargando…

Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer

CYP1B1 has been evaluated as a candidate gene for various cancers because of its function in activating environmental procarcinogens and catalysing the conversion of oestrogens to genotoxic catechol oestrogens. To test the hypothesis that genetic polymorphisms in the CYP1B1 gene may associate with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, B L, Zheng, S L, Isaacs, S D, Turner, A, Hawkins, G A, Wiley, K E, Bleecker, E R, Walsh, P C, Meyers, D A, Isaacs, W B, Xu, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394327/ https://www.ncbi.nlm.nih.gov/pubmed/14562027 http://dx.doi.org/10.1038/sj.bjc.6601288

Ejemplares similares

Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci
por: Brown, W M, et al.
Publicado: (2004)

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
por: Lindmark, F, et al.
Publicado: (2005)

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia
por: Tayeb, M T, et al.
Publicado: (2003)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Polymorphism of the insulin gene is associated with increased prostate cancer risk
por: Ho, G Y F, et al.
Publicado: (2003)

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
por: Gudmundsdottir, K, et al.
Publicado: (2003)

RsaI but not DraI polymorphism in CYP2E1 gene increases the risk of gastrointestinal cancer in Malaysians: a case–control study
por: Chong, Eric Tzyy Jiann, et al.
Publicado: (2014)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

Common germ-line polymorphism of C1QA and breast cancer survival
por: Azzato, E M, et al.
Publicado: (2010)

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population
por: Lesueur, F, et al.
Publicado: (2006)

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels
por: Jesser, C, et al.
Publicado: (2008)

Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma
por: Schernhammer, E S, et al.
Publicado: (2006)

CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk
por: Garcia-Albeniz, Xabier, et al.
Publicado: (2016)

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
por: Kadouri, L, et al.
Publicado: (2004)

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
por: Jakubowska, A, et al.
Publicado: (2012)

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
por: Osorio, A, et al.
Publicado: (2011)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
por: Quaye, L, et al.
Publicado: (2009)

A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma
por: Halsall, J A, et al.
Publicado: (2004)

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers
por: Osorio, A, et al.
Publicado: (2008)

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Sinilnikova, O M, et al.
Publicado: (2009)

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity
por: Ahmed, Mahbubl, et al.
Publicado: (2016)

Organisms with alternative genetic codes resolve unassigned codons via mistranslation and ribosomal rescue
por: Ma, Natalie Jing, et al.
Publicado: (2018)

Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer
por: Mrkonjic, M, et al.
Publicado: (2009)

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
por: Kote-Jarai, Z, et al.
Publicado: (2011)

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families
por: Ray, A M, et al.
Publicado: (2009)

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder
por: Sak, S C, et al.
Publicado: (2005)

CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites
por: Sood, Deepti, et al.
Publicado: (2017)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk
por: Baccarelli, A, et al.
Publicado: (2004)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study
por: Canzian, F, et al.
Publicado: (2006)

TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk
por: Skoglund Lundin, J, et al.
Publicado: (2009)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer
por: Julin, B, et al.
Publicado: (2015)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation
por: Marsh, H P, et al.
Publicado: (2003)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
por: Nam, R K, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4bct9g9sd6r80cqrq9jvaodgs7